Delivery Order SPE2DB22D1103-SPE2DB25FH0N2
Award Date 8/19/25
Potential Completion Date 9/10/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of INQOVI 35 MG-100 MG tablets in unit-of-issue quantities of 5 units. This is a firm fixed-price contract with an ultimate completion date of October 3, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,119.36 to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on August 29, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizing firm fixed pricing was issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for INQOVI 35 MG-100 MG tablets in a quantity of 5 units under a firm fixed-price contract with a ceiling value of $5,119.36. This non-competitive delivery order was issued on June 17, 2025, with an ultimate completion date of July 10, 2025, and reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement systems. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $10,238.74 to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets on September 12, 2025, with a completion date of October 3, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. INQOVI is a prescribed oncology medication used in the treatment of certain myelodysplastic syndromes and acute myeloid...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564134395! INQOVI 35 MG-100 MG TABLET UU 5S. The award, valued at $4,830.47, has an ultimate completion date of April 22, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, specializes in supplying pharmaceuticals, medical supplies, and related distribution services to...
- This is a $5,119.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of June 20, 2025 and is not set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for supplying a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- This $4,830.47 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product INQOVI 35 MG-100 MG TABLET with an ultimate completion date of July 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,660.94, is for the delivery of the specialty medication INQOVI 35 MG-100 MG TABLET with a completion date of March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as...